The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation: a retrospective study. [PDF]
Sasatsu S+13 more
europepmc +1 more source
Comparison of the euploidy rate in preimplantation genetic testing for aneuploidy cycles following progestin-primed versus gonadotropin-releasing hormone antagonist protocol: a randomized controlled study. [PDF]
Wang L+7 more
europepmc +1 more source
Understanding women's sex hormone physiology—A priority in diabetes care
Diabetic Medicine, Volume 42, Issue 10, October 2025.
Céline Isabelle Laesser+4 more
wiley +1 more source
Enduring differential patterns of neuronal loss and myelination along 6-month pulsatile gonadotropin-releasing hormone therapy in individuals with Down syndrome. [PDF]
Adamo M+11 more
europepmc +1 more source
Regulating Integrin β1 to Restore Gonadotropin-Releasing Hormone-Tanycyte Unit Function in Polycystic Ovary Syndrome-Related Hypothalamic Dysregulation. [PDF]
Wang Y+12 more
europepmc +1 more source
Gonadotropin Releasing Hormone Analogues in Gynaeocology
openaire +3 more sources
Tandem Administration of Prostaglandin F<sub>2α</sub> and Gonadotropin-Releasing Hormone in Beef Heifers and Cows as a Convergent Presynchronization Method in the 7 & 7 Synch Protocol. [PDF]
Palcheff LJ+11 more
europepmc +1 more source
Severe Early-onset Ovarian Hyperstimulation Syndrome with Isolated Pleural Effusion following Agonist Trigger in Gonadotropin-releasing Hormone Antagonist Cycle: A Case Report. [PDF]
Bhayana PD, Singh P, Passan S.
europepmc +1 more source
Breast cancer in a transgender man
CA: A Cancer Journal for Clinicians, Volume 75, Issue 5, Page 376-386, September/October 2025.
Alison May Berner+6 more
wiley +1 more source